DRUG · Bright Minds Biosciences Inc.
$77.42
-1.14 (-1.45%)
At close · Aug 21
Market Cap
$759.65M
Shares
9.81M
Price & Indicators
20d MA
50d MA
200d MA
Earnings
Filing
Insider
Congress
Investor day
Close$77.42
Open$78.89
Day$77.24–79.56
52W close$38.80–95.99
Avg vol 30d203K
Short int891K · 9.1% float · 4.1d
Short vol69%
Last earningsJan 6, 2026
DataJul 2023–Aug 2026
Raw chart and full-history price indicators begin at the captured split on Jul 14, 2023; bars on opposite sides are not compared.
Up next
FQ4-26 quarter ends
~Sep 30, 2026
Est
Equibles Rating
blended score · not investment adviceOverall
Neutral
SellHoldBuy
Technical
Neutral
Momentum
Weak
Sentiment
Bullish
Fundamentals
Limited
Quant / Vol
Very High
Market backdrop
VIX 15.1 · calm
Equity put/call 0.51
Technical
price trend
50 / 200-day cross
No cross
Price vs 200-day avg
+0%
above
Price vs 50-day avg
+7%
above
RSI (14)
50
neutral
MACD trend
Negative
52-week position
68%
mid-range
Volume (OBV)
Confirms
volume backs price
Momentum
relative strength
1-month return
+9%
trailing
6-month return
−7%
trailing
YTD return
−1%
this year
Relative strength
−18%
vs S&P · 6-mo
Sentiment
smart money
Trend (MA cross)
No cross
50d $72 › 200d $77 — 200d above 50d
Institutional flow
Accumulating
+5% holders QoQ · +20 funds added
Insider flow
Flat
No net insider activity over 90 days
Short interest
Falling
9.08% of float · ▼ -6.8% MoM · 4.1 days cover
Volume signal
Normal
Volume near normal
Institution breadth
Multi-yr high
99 holders — near 3-yr high, broad support
Squeeze score
68
elevated · 0–100
Fundamentals
Not enough data for a confident read.
Quant / Vol
risk profile
Volatility
70%
annualized · 1-yr
Max drawdown
−38%
past year
ATR
5.3%
of price · 14-day
Blended from price, momentum, positioning, fundamentals & volatility · daily-close · not investment advice. Market backdrop is context, not part of the score.
Technicals
trend & momentum for long-term holders Neutral
50 / 200-day cross
No cross
Neutral
Price vs 200-day avg
+0%
Bullish
Price vs 50-day avg
+7%
Bullish
RSI (14)
50
Neutral
MACD trend
Negative
Bearish
52-week position
68%
Neutral
Volume (OBV)
Confirms
Neutral
Market signals — smart money & positioning
Bullish · 3 of 6
Trend (MA cross)
No cross
50d $72 › 200d $77 — 200d above 50d
Institutional flow
Accumulating
+5% holders QoQ · +20 funds added
Insider flow
Flat
No net insider activity over 90 days
Short interest
Falling
9.08% of float · ▼ -6.8% MoM · 4.1 days cover
Volume signal
Normal
Volume near normal
Institution breadth
Multi-yr high
99 holders — near 3-yr high, broad support
Price context
position in its 52-week range
Range low $39
Now $77 · 68%
Range high $96
vs 200-day avg +0%
vs 50-day avg +7%
Illustrative technical + ownership context — a signal mix, not investment advice.
Versus peers
Biotechnology — same industry group| Company | Mkt cap | YTD | Rev growth Y/Y | P/E | Short % shares |
|---|---|---|---|---|---|
|
DRUG
this stock
Bright Minds Biosciences Inc.
|
$759.65M | -0.8% | — | — | 9.1% |
|
VRTX
Vertex Pharmaceuticals Inc / Ma
|
$138.91B | +20.9% | +46.2% | 31.9 | 1.6% |
|
REGN
Regeneron Pharmaceuticals, Inc.
|
$85.87B | +8.1% | +20.8% | 20.7 | 3.3% |
|
ARGX
Argenx SE
|
$64.66B | +23.6% | — | — | 2.1% |
|
CSLLY
Csl Ltd
|
$57.97B | — | — | — | 0.0% |
Peers by industry group · P/E from as-reported trailing EPS · short % is of shares outstanding
At a glance
key data from every sectionOwnership
Short & Settlement
Filings
Earnings & Events
Performance
Raw-price comparisons begin at the captured split on Jul 14, 2023; windows that need an earlier baseline remain unavailable.
| 5D | 20D | 120D | MTD | YTD | |
|---|---|---|---|---|---|
| DRUG | +1.3% | +8.5% | -6.5% | +5.7% | -0.8% |
| SPY | -1.4% | +3.6% | +11.6% | +2.5% | +12.3% |
| vs SPY | +2.7% | +4.9% | -18.1% | +3.2% | -13.1% |
Key facts
CIK
1827401
CUSIP
10919W405
13F (30d)
97 filings
96 filers
Visit website
Investor relations